Imaging subclinical atherosclerosis in cardiovascular risk stratification

Piepoli MF Hoes AW Agewall S , et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.

Ketola E Laatikainen T Vartiainen E. Evaluating risk for cardiovascular diseases–vain or value? How do different cardiovascular risk scores act in real life. Eur J Public Health 2010; 20: 107–112.

Bittencourt MS Blankstein R Blaha MJ , et al. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. Eur J Prev Cardiol 2018; 25: 1887–1898.

Fernández-Friera L Peñalvo JL Fernández-Ortiz A , et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation 2015; 131: 2104–2113.

Okwuosa TM Greenland P Ning H , et al. Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: The CARDIA study. JACC Cardiovasc Imaging 2012; 5: 923–930.

Lakoski SG Greenland P Wong ND , et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: The multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2007; 167: 2437–2442.

Östgren CJ Söderberg S Festin K , et al. SCORE estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries - A population-based cohort analysis from the Swedish cardiopulmonary BioImage study. Eur J Prev Cardiol 2020. Epub ahead of print; DOI: 10.1177/2047487320909300.

Baber U Mehran R Sartori S , et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: The BioImage study. J Am Coll Cardiol 2015; 65: 1065–1074.

Ornish D Scherwitz LW Billings JH , et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001–2007.

Lee SE Chang HJ Sung JM , et al. Effects of statins on coronary atherosclerotic plaques: The PARADIGM Study. JACC Cardiovasc Imaging 2018; 11: 1475–1484.

Newby DE. Computed tomography or functional stress testing for the prediction of risk: Can I have my cake and eat it? Circulation 2017; 136: 2006–2008.

Gepner AD Young R Delaney JA , et al. Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2017; 6: e005179.

Faggiano P Dasseni N Gaibazzi N , et al. Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence. Eur J Prev Cardiol 2019; 26: 1191–1204.